Perspective insights into hydrogels and nanomaterials for ischemic stroke

Ischemic stroke (IS) is a neurological disorder prevalent worldwide with a high disability and mortality rate. In the clinic setting, tissue plasminogen activator (tPA) and thrombectomy could restore blood flow of the occlusion region and improve the outcomes of IS patients; however, these therapies...

Full description

Bibliographic Details
Main Authors: Qingbo Yu, Zhang Jian, Dan Yang, Tao Zhu
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-01-01
Series:Frontiers in Cellular Neuroscience
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fncel.2022.1058753/full
_version_ 1828055987532070912
author Qingbo Yu
Qingbo Yu
Zhang Jian
Dan Yang
Tao Zhu
author_facet Qingbo Yu
Qingbo Yu
Zhang Jian
Dan Yang
Tao Zhu
author_sort Qingbo Yu
collection DOAJ
description Ischemic stroke (IS) is a neurological disorder prevalent worldwide with a high disability and mortality rate. In the clinic setting, tissue plasminogen activator (tPA) and thrombectomy could restore blood flow of the occlusion region and improve the outcomes of IS patients; however, these therapies are restricted by a narrow time window. Although several preclinical trials have revealed the molecular and cellular mechanisms underlying infarct lesions, the translatability of most findings is unsatisfactory, which contributes to the emergence of new biomaterials, such as hydrogels and nanomaterials, for the treatment of IS. Biomaterials function as structural scaffolds or are combined with other compounds to release therapeutic drugs. Biomaterial-mediated drug delivery approaches could optimize the therapeutic effects based on their brain-targeting property, biocompatibility, and functionality. This review summarizes the advances in biomaterials in the last several years, aiming to discuss the therapeutic potential of new biomaterials from the bench to bedside. The promising prospects of new biomaterials indicate the possibility of an organic combination between materialogy and medicine, which is a novel field under exploration.
first_indexed 2024-04-10T20:48:19Z
format Article
id doaj.art-b0bca5619c5545999c5bced7b5e8e15e
institution Directory Open Access Journal
issn 1662-5102
language English
last_indexed 2024-04-10T20:48:19Z
publishDate 2023-01-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Cellular Neuroscience
spelling doaj.art-b0bca5619c5545999c5bced7b5e8e15e2023-01-24T05:31:42ZengFrontiers Media S.A.Frontiers in Cellular Neuroscience1662-51022023-01-011610.3389/fncel.2022.10587531058753Perspective insights into hydrogels and nanomaterials for ischemic strokeQingbo Yu0Qingbo Yu1Zhang Jian2Dan Yang3Tao Zhu4Laboratory of Anesthesia & Critical Care Medicine, Department of Anesthesiology, Translational Neuroscience Center, West China Hospital of Sichuan University, Chengdu, ChinaDepartment of Anesthesiology, North Sichuan Medical College, Nanchong, ChinaSichuan Provincial Maternity and Child Health Care Hospital, Women’s and Children’s Hospital Affiliated of Chengdu Medical College, Chengdu, ChinaDepartment of Anesthesiology, North Sichuan Medical College, Nanchong, ChinaLaboratory of Anesthesia & Critical Care Medicine, Department of Anesthesiology, Translational Neuroscience Center, West China Hospital of Sichuan University, Chengdu, ChinaIschemic stroke (IS) is a neurological disorder prevalent worldwide with a high disability and mortality rate. In the clinic setting, tissue plasminogen activator (tPA) and thrombectomy could restore blood flow of the occlusion region and improve the outcomes of IS patients; however, these therapies are restricted by a narrow time window. Although several preclinical trials have revealed the molecular and cellular mechanisms underlying infarct lesions, the translatability of most findings is unsatisfactory, which contributes to the emergence of new biomaterials, such as hydrogels and nanomaterials, for the treatment of IS. Biomaterials function as structural scaffolds or are combined with other compounds to release therapeutic drugs. Biomaterial-mediated drug delivery approaches could optimize the therapeutic effects based on their brain-targeting property, biocompatibility, and functionality. This review summarizes the advances in biomaterials in the last several years, aiming to discuss the therapeutic potential of new biomaterials from the bench to bedside. The promising prospects of new biomaterials indicate the possibility of an organic combination between materialogy and medicine, which is a novel field under exploration.https://www.frontiersin.org/articles/10.3389/fncel.2022.1058753/fullstrokebiomaterialshydrogelsnanoparticlesneuroprotectionneurorestoration
spellingShingle Qingbo Yu
Qingbo Yu
Zhang Jian
Dan Yang
Tao Zhu
Perspective insights into hydrogels and nanomaterials for ischemic stroke
Frontiers in Cellular Neuroscience
stroke
biomaterials
hydrogels
nanoparticles
neuroprotection
neurorestoration
title Perspective insights into hydrogels and nanomaterials for ischemic stroke
title_full Perspective insights into hydrogels and nanomaterials for ischemic stroke
title_fullStr Perspective insights into hydrogels and nanomaterials for ischemic stroke
title_full_unstemmed Perspective insights into hydrogels and nanomaterials for ischemic stroke
title_short Perspective insights into hydrogels and nanomaterials for ischemic stroke
title_sort perspective insights into hydrogels and nanomaterials for ischemic stroke
topic stroke
biomaterials
hydrogels
nanoparticles
neuroprotection
neurorestoration
url https://www.frontiersin.org/articles/10.3389/fncel.2022.1058753/full
work_keys_str_mv AT qingboyu perspectiveinsightsintohydrogelsandnanomaterialsforischemicstroke
AT qingboyu perspectiveinsightsintohydrogelsandnanomaterialsforischemicstroke
AT zhangjian perspectiveinsightsintohydrogelsandnanomaterialsforischemicstroke
AT danyang perspectiveinsightsintohydrogelsandnanomaterialsforischemicstroke
AT taozhu perspectiveinsightsintohydrogelsandnanomaterialsforischemicstroke